Pricing
  1. US-listed companies
  2. EAGLE PHARMACEUTICALS, INC.
  3. Financials
  4. Common stock and paid-in capital

EAGLE PHARMACEUTICALS, INC.【EGRX】

Market cap
$14.29K
P/E ratio
SummaryFinancials
Period EndCommon stock and paid-in capital (Million USD)YoY (%)
Dec 31, 2022366+12.43%
Dec 31, 2021326+6.67%
Dec 31, 2020305+9.65%
Dec 31, 2019279+8.60%
Dec 31, 2018256+9.77%
Dec 31, 2017234+9.24%
Dec 31, 2016214+8.32%
Dec 31, 2015197+43.84%
Sep 30, 2014137

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)